Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...
Urination problems affect millions of men worldwide, often developing so gradually that many dismiss early warning signs.
Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) symptoms ...
The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.
Many people believe that urinary tract infections (UTIs) and incontinence are more common in women, but they can also affect ...
For most men ... bothersome urinary symptoms. BPH isn't prostate cancer and doesn't make you more likely to get it. There are many treatments for it, from lifestyle changes to medication to ...
In the OPD, every day, 5 in 10 men over 60 are complaining of urinary problems and are evaluated for BPH. Thus, an expert has ...